Monte Rosa Therapeutics, Inc. (GLUE)
14.31
+0.37
(+2.65%)
USD |
NASDAQ |
Sep 01, 16:00
14.31
0.00 (0.00%)
After-Hours: 19:41
Monte Rosa Therapeutics Total Long Term Debt (Quarterly) : 33.36M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.36M |
| March 31, 2026 | 34.58M |
| December 31, 2025 | 34.79M |
| September 30, 2025 | 35.93M |
| June 30, 2025 | 37.04M |
| March 31, 2025 | 38.00M |
| December 31, 2024 | 39.00M |
| September 30, 2024 | 40.05M |
| June 30, 2024 | 40.88M |
| March 31, 2024 | 41.84M |
| December 31, 2023 | 42.88M |
| September 30, 2023 | 43.52M |
| June 30, 2023 | 44.37M |
| Date | Value |
|---|---|
| March 31, 2023 | 43.28M |
| December 31, 2022 | 43.87M |
| September 30, 2022 | 42.59M |
| June 30, 2022 | 46.10M |
| March 31, 2022 | 5.457M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 231.17M |
| December 31, 2020 | 67.76M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Nurix Therapeutics, Inc. | 54.92M |
| Gilead Sciences, Inc. | 26.25B |
| Ironwood Pharmaceuticals, Inc. | 393.58M |
| Capricor Therapeutics, Inc. | 89.56M |
| Cue Biopharma, Inc. | 7.179M |